T1	Participants 74 94	postmenopausal women
T2	Participants 300 407	normotensive postmenopausal women receiving a fixed mid-range daily dose of conjugated equine oestrogen (CE
T3	Participants 433 495	Twenty normotensive postmenopausal women (median age 53 years)
